NEUBASE THERAPEUTICS, INC. Item 8.01. Other Events.
On October 17, 2023, NeuBase Therapeutics, Inc. (the "Company") received notice that Franklyn G. Prendergast, M.D., Ph.D., who served as a member of the Company's Board of Directors (the "Board") since July 2019, passed away. Dr. Prendergast was also a member of the Audit Committee and Compensation Committee of the Board.
The Company is grateful for Dr. Prendergast's many years of service and expresses its condolences to his family.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
NeuBase Therapeutics Inc. published this content on 20 October 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 October 2023 11:32:34 UTC.
